• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of May 29, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles (NDC 60793-859-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
Recall Number D-430-2013
Classification Class II
Code Info Lot # a) 64329, Exp. 5/13; 65229, Exp. 6/13; and 65913, Exp. 9/13; b) 64330, Exp. 5/13; 65230, Exp. 6/13; and 65915, Exp. 9/13
Product Distributed Qty 51,438 bottles
Reason For Recall Subpotent Drug: The products were below specification for potency at the expiry stability point.

Event Detail

Event Id 65172
Product Type Drugs
Status Ongoing
Recalling Firm King Legacy, a wholly owned subsidiary of Pfizer
City Bristol
State TN
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-04-30
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide and Puerto Rico